![Jaume Pons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaume Pons
Founder at
Alx Oncology Ltd.
Net worth: 939 966 $ as of 2026-05-30
Profile
Dr. Jaume Pons is a President, Chief Executive Officer & Director at ALX Oncology Ltd. and a Scientific Advisor at LSV Capital Management LLC.
He is on the Board of Directors at ALX Oncology Ltd., Alexo Therapeutics International, Sirpant Therapeutics and Tallac Therapeutics, Inc.
Dr. Pons was previously employed as a President & Chief Scientific Officer by ALX Oncology Holdings, Inc., a Venture Partner by venBio Partners LLC, a Chief Scientific Officer by Rinat Neuroscience Corp., a President & Chief Executive Officer by ALX Oncology, Inc., and a Chief Technology Officer by Pfizer Inc.
He received his undergraduate degree from Autonomous University of Barcelona, a graduate degree from the University of California, Berkeley, a graduate degree from Autonomous University of Barcelona and a doctorate degree from Autonomous University of Barcelona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 494,719 ( 0.37% ) | 939 966 $ | 2026-05-30 |
Jaume Pons active positions
| Companies | Position | Start |
|---|---|---|
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Founder | 2015-03-31 |
Alexo Therapeutics International
 Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Director/Board Member | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Founder | - |
Sirpant Therapeutics | Director/Board Member | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Consultant / Advisor | - |
Former positions of Jaume Pons
| Companies | Position | End |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Chief Executive Officer | 2023-09-05 |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Chief Tech/Sci/R&D Officer | 2015-01-31 |
| PFIZER INC. | Chief Tech/Sci/R&D Officer | - |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Chief Executive Officer | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Training of Jaume Pons
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Autonomous University of Barcelona
 Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Alx Oncology Ltd.
Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Alexo Therapeutics International
Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
Sirpant Therapeutics |
- Stock Market
- Insiders
- Jaume Pons
Choose MarketScreener 
